DNTH – dianthus therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Dianthus Therapeutics (NASDAQ:DNTH) had its price target raised by analysts at Wedbush from $46.00 to $55.00. They now have an "outperform" rating on the stock.
Dianthus Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 [Yahoo! Finance]
Dianthus Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026
Dianthus Therapeutics (NASDAQ:DNTH) had its price target raised by analysts at Jefferies Financial Group Inc. from $66.00 to $81.00. They now have a "buy" rating on the stock.
Assessing Dianthus Therapeutics (DNTH) Valuation As Price To Book Sits Near 3x And Shares Show Mixed Returns [Yahoo! Finance]
Form 4 Dianthus Therapeutics, For: Feb 03 Filed by: CARR EDWARD
Form 4 Dianthus Therapeutics, For: Feb 03 Filed by: Veness Adam M
Form 4 Dianthus Therapeutics, For: Feb 03 Filed by: Randhawa Simrat
Form 4 Dianthus Therapeutics, For: Feb 03 Filed by: Savitz Ryan
Form 4 Dianthus Therapeutics, For: Feb 03 Filed by: Garcia Marino
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.